Jörg
Prinzlin¹, Alison Campbell² and Nick Sutcliffe¹
1.
Department of Anaesthesia, Golden Jubilee National Hospital, Clydebank G81 4HX,
Scotland
2.
University Department of Anaesthesia, Glasgow Royal Infirmary
Background
and Goal of Study:
Numerous
pharmakokinetic/pharmakodynamic (PK/PD) models for propofol, suitable for
driving target controlled infusion (TCI) devices, are now available. These
models will predict differing blood and effect site concentrations for a given
infusion regimen. Propofol effect is more accurately reflected by effect-site
concentration than plasma concentration. Postulating that an ideal model would
predict the same effect-site concentration at loss, and regaining, of
consciousness, we compared the predictive accuracy of 4 different PK/PD models
for TCI propofol. We correlated the predicted effect site concentration at loss
and return of clinical endpoints in elderly patients.
|
|
Marsh |
Schuttler |
Schnider |
White-Kenny |
|
LOER1/ROER
|
0.29 |
0.27 |
0.13 |
0.46 |
|
LOER2/ROER |
0.78 |
0.53 |
0.36 |
0.71 |
|
LOVR1/ROVR |
0.05 |
0.02 |
0.02 |
0.1 |
|
LOVR2/ROVR |
0.90 |
0.76 |
0.47 |
0.84 |
|
|
|
|
|
|
|
LOER1/LOER2 |
0.33 |
0.29 |
0.1 |
0.36 |
|
LOVR1/LOVR2 |
0.13 |
0.09 |
0.28 |
0.2 |
The
White-Kenny and Marsh models had the best correlation between similar clinical
endpoints except for LOVR1/LOVR2. The Schnider model had the lowest correlation
in all comparisons except when comparing LOVR1/LOVR2.
1)
Marsh B. BJA 1991; 67:41-8
2)
Schnider T. Anesthesiology
1999; 90: 1502-16
3)
Schüttler J. Anesthesiology 2000; 92:727-73